The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious approach when it comes to buying other companies, which are expensively priced.

Key Takeaways Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck ...

Merck & Co., Inc. (NYSE:MRK) is a prominent global healthcare company that focuses on the research, development, and commercialization of a wide range of pharmaceutical products.

Merck just rewarded its shareholders again with a dividend hike. This Dow stock has come with a quarterly dividend for almost ...

Several New Jersey-based companies have earned high rankings in Newsweek’s 2024 list of America’s Most Trustworthy Companies.

Merck's total revenue came in at $16.7 billion, 4% higher than the year-ago period. The medicine has an impressive list of approvals ... but it is working on new products, too.

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other pharma ...

As for branded products, Merck’s (NYSE:MRK) cancer blockbuster dominates the list, and the checkpoint inhibitor is on track to generate peak sales in 2025, Evaluate Pharma projects. The New ...

The final category of products provides materials for the production of semiconductors. Merck & Co.'s top clients are pharmaceutical companies, academic institutions, technology firms, and ...

(Reuters) -UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's therapy to treat a rare lung condition, marking another win for the drugmaker's potential ...